Duffort O A, Carreira J, Nitti G, Polo F, Lombardero M
Departamento de Investigación, Algeria e Immunología Abelló S.A., Madrid, Spain.
Mol Immunol. 1991 Apr-May;28(4-5):301-9. doi: 10.1016/0161-5890(91)90141-6.
The major cat allergen, Fel d I, was purified to homogeneity from cat dander extract by sequential mAb affinity chromatography and HPLC size exclusion. The purity and allergenic activity of the preparation was demonstrated by different techniques such as HPLC, RAST inhibition, skin prick tests and CIE/CRIE. Fel d I showed a mol. wt of about 35,000 by HPLC gel filtration and of 18,000 by SDS-PAGE, confirming that it is a non-covalently linked dimer. However, SDS-PAGE analysis under reducing conditions as well as labelling experiments with 14C-iodoacetamide of 2-ME-reduced Fel d I showed that each mol. wt 18,000 monomer is comprised of two covalently S-S bound polypeptides with apparent mol. wt. of 4000 (alpha-chain) and 14,000 (beta-chain). Reduction and alkylation of Fel d I obliterated most of its allergenic activity, as determined by RAST inhibition and immunoblotting, suggesting that most of the IgE-binding sites are conformational. On the other hand, treatment of Fel d I by N-glycanase under reducing and non-reducing conditions indicated the presence of N-linked oligosaccharides in the beta-chain. Carbohydrate analysis data of the whole Fel d I molecule showed the presence of a relatively high carbohydrate content (approximately 20%). RAST inhibition experiments of native and deglycosilated allergen suggest that most IgE epitopes are located in the protein moiety of the molecule. However, the deglycosilated allergen showed a 2-4 fold reduction in its inhibition capacity of RAST as compared to the native allergen, suggesting that carbohydrates could have some role in keeping the active conformation of those epitopes. The N-terminal amino acid sequence of the beta-chain (20 residues) and most of the alpha-chain (40 residues) were determined. Both chain sequences showed no homology with other known protein sequences.
主要的猫过敏原Fel d I,通过单克隆抗体亲和层析和高效液相色谱尺寸排阻法从猫皮屑提取物中纯化至同质。通过不同技术如高效液相色谱、放射性过敏原吸附抑制试验(RAST抑制)、皮肤点刺试验和免疫电泳/交叉免疫电泳(CIE/CRIE)证明了该制剂的纯度和致敏活性。通过高效液相色谱凝胶过滤法测定,Fel d I的分子量约为35,000,通过十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)测定为18,000,证实它是一种非共价连接的二聚体。然而,在还原条件下的SDS-PAGE分析以及用14C-碘乙酰胺对2-巯基乙醇还原的Fel d I进行的标记实验表明,每个分子量为18,000的单体由两个通过二硫键共价结合的多肽组成,其表观分子量分别为4000(α链)和14,000(β链)。通过RAST抑制和免疫印迹法测定,Fel d I的还原和烷基化消除了其大部分致敏活性,这表明大多数免疫球蛋白E(IgE)结合位点是构象性的。另一方面,在还原和非还原条件下用N-糖苷酶处理Fel d I表明β链中存在N-连接寡糖。整个Fel d I分子的碳水化合物分析数据显示存在相对较高的碳水化合物含量(约20%)。天然和去糖基化过敏原的RAST抑制实验表明,大多数IgE表位位于分子的蛋白质部分。然而,与天然过敏原相比,去糖基化过敏原的RAST抑制能力降低了2至4倍,这表明碳水化合物可能在维持这些表位的活性构象中起一定作用。测定了β链(20个残基)和大部分α链(40个残基)的N端氨基酸序列。两条链的序列与其他已知蛋白质序列均无同源性。